Next-Generation/NN
Sequencing/NN
and/CC
Epigenomics/NNS
Research/NN
:/:
A/DT
Hammer/NN
in/IN
Search/NN
of/IN
Nails/NNS
./.
====================
After/IN
the/DT
initial/JJ
enthusiasm/NN
of/IN
the/DT
human/JJ
genome/NN
project/VB
,/,
it/PRP
became/VBD
clear/JJ
that/IN
without/IN
additional/JJ
data/NNS
pertaining/VBG
to/TO
the/DT
epigenome/JJ
,/,
i.e./FW
,/,
how/WRB
the/DT
genome/NN
is/VBZ
marked/JJ
at/IN
specific/JJ
developmental/JJ
periods/NNS
,/,
in/IN
different/JJ
tissues/NNS
,/,
as/IN
well/RB
as/IN
across/IN
individuals/NNS
and/CC
species-the/DT
promise/RB
of/IN
the/DT
genome/NN
sequencing/NN
project/JJ
in/IN
understanding/VBG
biology/NN
can/MD
not/RB
be/VB
fulfilled/VBN
./.
====================
This/DT
realization/NN
prompted/VBD
several/JJ
large-scale/JJ
efforts/NNS
to/TO
map/VB
the/DT
epigenome/JJ
,/,
most/JJS
notably/RB
the/DT
Encyclopedia/NN
of/IN
DNA/NN
Elements/NNS
(/(
ENCODE/NN
)/)
project/VBP
./.
====================
While/IN
there/EX
is/VBZ
essentially/RB
a/DT
single/JJ
genome/NN
in/IN
an/DT
individual/JJ
,/,
there/EX
are/VBP
hundreds/VBZ
of/IN
epigenomes/NNS
,/,
corresponding/VBG
to/TO
various/JJ
types/NNS
of/IN
epigenomic/JJ
marks/NNS
at/IN
different/JJ
developmental/JJ
times/NNS
and/CC
in/IN
multiple/JJ
tissue/NN
types/NNS
./.
====================
Unprecedented/JJ
advances/NNS
in/IN
next-generation/JJ
sequencing/NN
(/(
NGS/NN
)/)
technologies/VBZ
,/,
by/IN
virtue/NN
of/IN
low/JJ
cost/JJ
and/CC
high/JJ
speeds/VBZ
that/IN
continue/VBP
to/TO
improve/VB
at/IN
a/DT
rate/NN
beyond/IN
what/WP
is/VBZ
anticipated/JJ
by/IN
Moore/RBR
's/POS
law/NN
for/IN
computer/NN
hardware/VBP
technologies/NNS
,/,
have/VBP
revolutionized/VBN
molecular/JJ
biology/NN
and/CC
genetics/NNS
research/NN
,/,
and/CC
have/VBP
in/IN
turn/NN
prompted/VBD
innovative/JJ
ways/NNS
to/TO
reduce/VB
the/DT
problem/NN
of/IN
measuring/VBG
cellular/JJ
events/NNS
involving/VBG
DNA/NN
or/CC
RNA/NN
into/IN
a/DT
sequencing/JJ
problem/NN
./.
====================
In/IN
this/DT
article/NN
,/,
we/PRP
provide/VBP
a/DT
brief/JJ
overview/NN
of/IN
the/DT
epigenome/JJ
,/,
the/DT
various/JJ
types/NNS
of/IN
epigenomic/JJ
data/NNS
afforded/VBD
by/IN
NGS/NN
,/,
and/CC
some/DT
of/IN
the/DT
novel/JJ
discoveries/NNS
yielded/VBD
by/IN
the/DT
epigenomics/NNS
projects/NNS
./.
====================
We/PRP
also/RB
provide/VBP
ample/JJ
references/VBZ
for/IN
the/DT
reader/NN
to/TO
get/VB
in-depth/IN
information/NN
on/IN
these/DT
topics/NNS
./.
====================
Next-generation/NN
sequencing/NN
(/(
NGS/NN
)/)
has/VBZ
resulted/VBD
in/IN
an/DT
exponential/JJ
growth/NN
in/IN
data/NNS
in/IN
the/DT
past/NN
decade/NN
,/,
primarily/RB
fueled/VBN
by/IN
the/DT
general/JJ
interest/NN
of/IN
the/DT
scientific/JJ
community/NN
in/IN
functionally/RB
annotating/VBG
the/DT
human/JJ
genome/NN
./.
====================
The/DT
power/JJR
of/IN
high-throughput/JJ
parallel/JJ
sequencing/NN
was/VBD
deployed/VBN
to/TO
characterize/VB
human/JJ
genetic/JJ
variation/NN
,/,
in/IN
an/DT
international/JJ
effort/NN
launched/VBN
in/IN
2008/CD
,/,
called/VBN
the/DT
1000/CD
Genomes/NNS
Project/JJ
,/,
with/IN
the/DT
hope/NN
that/DT
such/JJ
a/DT
large-scale/JJ
endeavor/JJ
would/MD
help/VB
in/IN
identifying/VBG
all/DT
the/DT
underlying/VBG
genetic/JJ
differences/NNS
that/IN
lead/VBP
to/TO
disease/NN
resistance/susceptibility/NN
[/(
1/CD
]/)
./.
====================
In/IN
the/DT
meantime/NN
,/,
based/VBN
on/IN
numerous/JJ
genome-wide/NN
association/NN
studies/NNS
(/(
GWAS/NN
)/)
,/,
it/PRP
was/VBD
realized/VBN
that/IN
93/CD
%/NN
of/IN
the/DT
trait-associated/JJ
polymorphisms/NNS
within/IN
the/DT
human/JJ
population/NN
were/VBD
located/JJ
in/IN
non-coding/JJ
regions/NNS
,/,
potentially/RB
within/IN
cis-regulatory/JJ
elements/NNS
[/(
2/CD
]/)
./.
====================
In/IN
fact/NN
,/,
in/IN
the/DT
mid-1970s/NNS
,/,
King/VBG
and/CC
Wilson/NN
[/(
3/CD
]/)
pointed/VBD
out/RP
the/DT
importance/NN
of/IN
mapping/VBG
regulatory/JJ
events/NNS
and/CC
hinted/JJ
that/DT
a/DT
small/JJ
difference/NN
in/IN
the/DT
time/level/JJ
of/IN
activation/NN
of/IN
a/DT
single/JJ
gene/NN
could/MD
influence/VB
overall/JJ
systemic/JJ
development/NN
./.
====================
They/PRP
estimated/VBN
the/DT
genetic/JJ
distance/NN
between/IN
human/JJ
and/CC
chimpanzee/NN
to/TO
be/VB
much/RB
smaller/JJR
than/IN
the/DT
corresponding/JJ
genetic/JJ
distance/NN
between/IN
the/DT
sibling/NN
species/NNS
of/IN
Drosophila/FW
,/,
thereby/RB
underscoring/VBG
the/DT
need/JJ
to/TO
explore/VB
regulatory/expression/NN
differences/NNS
at/IN
different/JJ
times/NNS
as/IN
a/DT
basis/NN
to/TO
explain/VB
the/DT
evolutionary/JJ
differences/NNS
at/IN
the/DT
organismal/JJ
level/NN
[/(
3/CD
]/)
./.
====================
A/DT
mechanistic/JJ
understanding/NN
of/IN
spatio-temporal/JJ
gene/NN
expression/NN
in/IN
eukaryotes/NNS
is/VBZ
far/RB
from/IN
complete/JJ
./.
====================
While/IN
genetic/JJ
differences/NNS
might/MD
be/VB
expected/VBN
to/TO
explain/VB
expression/NN
divergence/RB
across/IN
species/NNS
and/CC
expression/NN
variability/NN
across/IN
individuals/NNS
of/IN
a/DT
population/NN
,/,
it/PRP
can/MD
not/RB
explain/VB
how/WRB
almost-identical/JJ
genomes/NNS
in/IN
more/RBR
than/IN
200/CD
different/JJ
cell/NN
types/NNS
within/IN
an/DT
individual/JJ
organism/NN
can/MD
drive/VB
such/JJ
varied/VBD
expression/NN
profiles/NNS
specific/JJ
to/TO
each/DT
cell/NN
type/NN
[/(
4/CD
]/)
./.
====================
DNA/NN
is/VBZ
packaged/VBN
in/IN
a/DT
nucleoprotein/NN
complex/NN
structure/NN
called/VBN
chromatin/NN
that/DT
is/VBZ
highly/RB
dynamic/JJ
,/,
in/IN
that/DT
its/PRP$
``/NN
states/NNS
''/CD
vary/VBP
from/IN
one/CD
cell/NN
type/NN
to/TO
another/DT
./.
====================
Therefore/RB
,/,
a/DT
possible/JJ
solution/NN
to/TO
this/DT
conundrum/NN
is/VBZ
to/TO
analyze/VB
these/DT
``/NN
states/NNS
''/CD
at/IN
the/DT
genome/NN
level/NN
,/,
i.e./FW
,/,
characterize/VBP
the/DT
landscape/NN
of/IN
the/DT
epigenome/JJ
,/,
which/WDT
further/RB
qualifies/NNS
and/CC
modulates/VBZ
the/DT
functional/JJ
effect/NN
of/IN
genetic/JJ
information/NN
[/(
5/CD
]/)
./.
====================
Epigenome/DT
,/,
meaning/VBG
``/CD
on/IN
or/CC
above/JJ
genomes/NNS
,/,
''/NNP
refers/VBZ
to/TO
such/JJ
sequence-independent/JJ
heritable/JJ
properties/NNS
of/IN
the/DT
genome/NN
that/IN
can/MD
modulate/VB
the/DT
functional/JJ
output/NN
of/IN
the/DT
genome/NN
./.
====================
While/IN
,/,
as/IN
described/VBN
initially/RB
,/,
heritability/RB
is/VBZ
an/DT
important/JJ
qualifying/VBG
criterion/JJ
of/IN
an/DT
epigenomic/JJ
mark/VBP
(/(
most/JJS
notably/RB
,/,
DNA/NN
methylation/NN
)/)
[/(
6/CD
]/)
,/,
currently/RB
,/,
the/DT
term/NN
epigenome/DT
is/VBZ
loosely/RB
used/VBN
to/TO
encompass/VB
a/DT
myriad/JJ
of/IN
chemical/JJ
changes/NNS
to/TO
DNA/NN
or/CC
histone/NN
proteins/NNS
,/,
chromatin/NN
accessibility/NN
,/,
small/JJ
and/CC
long/JJ
(/(
non-coding/JJ
)/)
RNA/NN
localization/NN
,/,
and/CC
higher-order/JJ
DNA/NN
organization/NN
(/(
including/VBG
nucleosome/JJ
occupancy/NN
and/CC
positioning/JJ
,/,
and/CC
3D/NN
chromatin/NN
interactions/NNS
)/)
(/(
Fig/NN
./.
====================
1/CD
)/)
[/(
7,8,9/CD
]/)
./.
====================
The/DT
ultimate/JJ
combined/JJ
effect/NN
of/IN
the/DT
epigenome/JJ
is/VBZ
to/TO
determine/VB
the/DT
transcriptome/JJ
(/(
the/DT
set/NN
of/IN
all/DT
transcripts/NNS
)/)
of/IN
a/DT
cell/NN
precisely/RB
./.
====================
Epigenomic/JJ
features/NNS
influence/RB
the/DT
regulatory/JJ
program/NN
of/IN
each/DT
gene/NN
's/POS
expression/NN
in/IN
several/JJ
ways/NNS
:/:
they/PRP
define/VBP
the/DT
local/JJ
environment/NN
of/IN
specific/JJ
processes/NNS
by/IN
regulating/VBG
the/DT
chromatin/NN
architecture/NN
,/,
determine/VBP
access/IN
of/IN
transcription/NN
factors/NNS
to/TO
DNA/NN
,/,
as/IN
well/RB
as/IN
serve/VBP
to/TO
keep/VB
a/DT
``/JJ
memory/NN
''/RB
of/IN
cell/NN
type-specific/JJ
features/NNS
facilitating/VBG
heritability/NN
of/IN
epigenetic/JJ
characteristics/NNS
[/(
10/CD
,/,
11/CD
]/)
./.
====================
The/DT
will/JJ
of/IN
the/DT
global/JJ
scientific/JJ
community/NN
to/TO
sequence/NN
the/DT
human/JJ
genome/NN
spurred/VBN
advances/NNS
in/IN
sequencing/NN
technologies/NNS
that/DT
led/VBD
to/TO
what/DT
is/VBZ
now/RB
known/VBN
as/IN
NGS/NN
./.
====================
The/DT
improvement/JJ
in/IN
cost/JJ
and/CC
speed/RB
of/IN
sequencing/NN
in/IN
the/DT
last/JJ
decade/NN
has/VBZ
significantly/RB
surpassed/VBD
the/DT
analogous/JJ
improvement/NN
in/IN
computer/NN
technologies/NNS
as/IN
predicted/VBN
by/IN
Moore/RBR
's/POS
law/NN
[/(
12/CD
]/)
./.
====================
Well/DT
beyond/CC
the/DT
initial/JJ
goal/NN
of/IN
sequencing/VBG
complete/JJ
genomes/NNS
of/IN
several/JJ
species/NNS
,/,
NGS/NN
is/VBZ
now/RB
routinely/RB
used/VBN
as/IN
a/DT
tool/NN
to/TO
investigate/VB
the/DT
diverse/JJ
array/NN
of/IN
cellular/JJ
events/NNS
involving/VBG
DNA/NN
or/CC
RNA/NN
,/,
such/JJ
as/IN
the/DT
identification/NN
of/IN
genomic/JJ
loci/NNS
bound/VBD
by/IN
a/DT
specific/JJ
protein/NN
,/,
the/DT
detection/NN
of/IN
pairs/NNS
of/IN
spatially/RB
proximal/JJ
or/CC
interacting/VBG
chromosomal/JJ
loci/NNS
,/,
etc/JJ
./.
====================
Broad/RB
availability/NN
of/IN
NGS/NN
technologies/NNS
has/VBZ
led/VBD
to/TO
a/DT
paradigm/NN
shift/NN
in/IN
molecular/JJ
biology/NN
research/RB
;/:
from/IN
probing/VBG
singular/JJ
cellular/JJ
events/NNS
to/TO
an/DT
unbiased/JJ
genome-scale/JJ
mapping/VBG
of/IN
such/JJ
events/NNS
,/,
and/CC
has/VBZ
enabled/VBN
genome-wide/NN
elucidation/NN
of/IN
the/DT
epigenomic/JJ
landscapes/NNS
in/IN
hundreds/VBZ
of/IN
cell/NN
types/NNS
,/,
across/IN
developmental/JJ
times/NNS
,/,
in/IN
human/JJ
,/,
as/IN
well/RB
as/IN
other/JJ
species/NNS
[/(
13/CD
]/)
.As/IN
mentioned/JJ
earlier/RBR
,/,
it/PRP
is/VBZ
the/DT
locus-specific/JJ
``/RB
epigenetic/JJ
code/VBP
''/RB
(/(
a/DT
specific/JJ
signature/JJ
or/CC
combination/NN
of/IN
several/JJ
epigenetic/JJ
modifications/NNS
)/)
that/IN
helps/VBZ
define/RB
a/DT
cell/NN
's/POS
expression/NN
program/NN
and/CC
identity/NN
[/(
14/CD
]/)
,/,
thereby/RB
distinguishing/VBG
it/PRP
from/IN
other/JJ
cell/NN
types/NNS
./.
====================
Unlike/IN
the/DT
largely/RB
static/JJ
genome/NN
of/IN
an/DT
individual/JJ
,/,
the/DT
epigenome/JJ
is/VBZ
highly/RB
variable/JJ
and/CC
dynamic/JJ
;/:
yet/RB
,/,
many/JJ
of/IN
these/DT
marks/NNS
can/MD
be/VB
passed/VBN
down/RB
a/DT
cell/NN
's/POS
lineage/NN
,/,
or/CC
from/IN
one/CD
generation/NN
to/TO
the/DT
next/JJ
./.
====================
In/IN
this/DT
section/NN
,/,
we/PRP
describe/VBP
several/JJ
well-studied/JJ
epigenomic/JJ
marks/NNS
and/CC
outline/NN
what/WP
is/VBZ
known/VBN
about/IN
their/PRP$
role/NN
in/IN
gene/NN
expression/NN
modulation/NN
./.
====================
We/PRP
will/MD
also/RB
outline/IN
various/JJ
NGS-based/JJ
assays/NNS
that/IN
are/VBP
used/VBN
in/IN
comprehensively/RB
mapping/VBG
each/DT
of/IN
the/DT
epigenetic/JJ
marks/NNS
(/(
Table/JJ
1/CD
)/)
[/(
15/CD
,/,
16/CD
,/,
17/CD
,/,
18/CD
,/,
19/CD
,/,
20/CD
,/,
21/CD
,/,
22/CD
,/,
23/CD
,/,
24/CD
,/,
25/CD
,/,
26/CD
,/,
27/CD
,/,
28/CD
,/,
29/CD
,/,
30/CD
,/,
31/CD
,/,
32/CD
,/,
33/CD
,/,
34/CD
]/)
./.
====================
DNA/NN
methylation/NN
====================
One/CD
of/IN
the/DT
more/RBR
stable/JJ
and/CC
heritable/JJ
epigenetic/JJ
marks/NNS
is/VBZ
DNA/NN
methylation/NN
./.
====================
The/DT
human/JJ
genome/NN
is/VBZ
highly/RB
methylated/VBN
;/:
approximately/RB
80/CD
%/NN
of/IN
cytosines/NNS
in/IN
CpG/NN
dinucleotides/NNS
are/VBP
chemically/RB
modified/VBN
at/IN
their/PRP$
fifth/JJ
carbon/NN
atom/IN
with/IN
a/DT
methyl/JJ
group/NN
[/(
35/CD
]/)
./.
====================
Historically/RB
,/,
DNA/NN
methylation/NN
was/VBD
associated/VBN
with/IN
transcriptional/JJ
silencing/NN
(/(
as/IN
evidenced/VBN
by/IN
many/JJ
promoter-based/VBN
studies/NNS
)/)
[/(
36/CD
]/)
./.
====================
Although/IN
genome-scale/JJ
profiling/VBG
of/IN
this/DT
epigenetic/JJ
mark/VBP
revealed/VBD
that/IN
in/IN
some/DT
instances/NNS
DNA/NN
methylation/NN
is/VBZ
correlated/VBN
with/IN
transcriptional/JJ
activation/NN
,/,
it/PRP
is/VBZ
enriched/VBN
in/IN
the/DT
gene/NN
bodies/NNS
of/IN
active/JJ
genes/NNS
[/(
37/CD
]/)
./.
====================
Thus/RB
,/,
the/DT
associations/NNS
between/IN
an/DT
epigenomic/JJ
mark/VBP
and/CC
functional/JJ
output/NN
may/MD
be/VB
location-specific/JJ
,/,
thereby/RB
complicating/VBG
their/PRP$
functional/JJ
interpretation/NN
./.
====================
The/DT
available/JJ
assays/NNS
for/IN
identifying/VBG
methylated/VBN
CpG/NN
dinucleotides/NNS
in/IN
a/DT
genome/NN
vary/VBP
in/IN
terms/NNS
of/IN
resolution/NN
and/CC
cost/JJ
./.
====================
Restriction/NN
enzyme-based/JJ
assays/NNS
(/(
e.g./FW
,/,
methylation-sensitive/JJ
restriction/NN
enzyme/NN
sequencing/NN
)/)
involve/VBP
the/DT
digestion/NN
of/IN
genomic/JJ
DNA/NN
with/IN
several/JJ
methylation-sensitive/JJ
enzymes/NNS
[/(
15/CD
]/)
,/,
followed/VBN
by/IN
sequencing/VBG
of/IN
digested/JJ
fragments/NNS
./.
====================
Affinity-based/JJ
enrichment/JJ
assays/NNS
,/,
such/JJ
as/IN
methylated/VBN
DNA/NN
immunoprecipitation/NN
sequencing/NN
and/CC
methyl-CpG-binding/JJ
domain/NN
protein/NN
sequencing/NN
[/(
16/CD
,/,
17/CD
]/)
,/,
selectively/RB
target/NN
methylated/VBN
fragments/NNS
(/(
usually/RB
up/IN
to/TO
100/CD
bp/NN
)/)
using/VBG
an/DT
antibody/NN
,/,
followed/VBN
by/IN
sequencing/VBG
of/IN
those/DT
fragments/NNS
./.
====================
Both/DT
these/DT
methods/NNS
are/VBP
low-resolution/JJ
and/CC
essentially/RB
qualitative/JJ
./.
====================
Chemical/JJ
modification/NN
methods/NNS
,/,
such/JJ
as/IN
bisulfite/JJ
sequencing/NN
(/(
BS/NN
)/)
,/,
have/VBP
higher/JJR
resolution/NN
and/CC
provide/VBP
quantitative/JJ
estimates/NNS
of/IN
methylation/NN
./.
====================
They/PRP
exploit/VBP
the/DT
fact/NN
that/IN
when/WRB
treated/VBN
with/IN
sodium/NN
bisulfite/NN
,/,
unmethylated/JJ
cytosines/NNS
convert/VB
to/TO
uracil/NN
while/IN
methylated/VBN
cytosines/NNS
do/VBP
not/RB
./.
====================
Thus/RB
,/,
mapping/VBG
of/IN
sequenced/VBN
fragments/NNS
reveals/VBZ
the/DT
quantitative/JJ
estimate/NN
of/IN
methylation/NN
at/IN
each/DT
CpG/NN
locus/NN
./.
====================
The/DT
two/CD
variations/NNS
to/TO
BS/NN
include/VBP
reduced/VBD
representation/NN
BS/NN
and/CC
whole-genome/JJ
bisulfite/NN
sequencing/NN
,/,
or/CC
methylC-seq/JJ
(/(
whole-genome/DT
BS/NN
)/)
;/:
the/DT
former/JJ
employs/VBZ
restriction/NN
enzyme/NN
digestion/NN
to/TO
target/NN
certain/JJ
regions/NNS
of/IN
interest/JJ
prior/RB
to/TO
sodium/NN
bisulfite/NN
treatment/NN
[/(
18/CD
]/)
,/,
whereas/IN
the/DT
latter/JJ
couples/NNS
the/DT
chemical/JJ
treatment/NN
with/IN
whole-genome/DT
sequencing/NN
[/(
19/CD
]/)
./.
====================
Upon/IN
the/DT
discovery/NN
that/DT
5-hydroxymethylcytosine/JJ
(/(
5-hmC/NN
:/:
an/DT
intermediate/JJ
produced/VBN
during/IN
active/JJ
DNA/NN
demethylation/NN
)/)
and/CC
5-methylcytosine/JJ
(/(
5-mC/NN
)/)
are/VBP
both/DT
resistant/JJ
to/TO
bisulfite/VB
treatment/NN
,/,
it/PRP
became/VBD
critical/JJ
to/TO
distinguish/VB
between/IN
the/DT
different/JJ
methyl/NN
variants/NNS
,/,
including/VBG
5-formylcytosine/JJ
and/CC
5-carboxylcytosine/JJ
./.
====================
To/TO
this/DT
end/NN
,/,
oxidative/JJ
bisulfite/NN
sequencing/NN
(/(
oxBS-seq/NN
)/)
was/VBD
invented/VBN
as/IN
an/DT
improvement/NN
for/IN
methylC-seq/JJ
to/TO
measure/VB
single/JJ
base-pair/NN
resolution/NN
methylation/NN
levels/NNS
of/IN
5-mC/JJ
[/(
20/CD
]/)
./.
====================
This/DT
is/VBZ
accomplished/VBN
by/IN
oxidizing/VBG
5-hmCs/NNS
(/(
using/VBG
potassium/NN
perruthenate/NN
)/)
before/IN
sodium/NN
bisulfite/NN
treatment/NN
,/,
such/JJ
that/IN
they/PRP
are/VBP
now/RB
sensitive/JJ
to/TO
the/DT
subjected/VBN
chemical/JJ
conversion/NN
to/TO
uracil/NN
,/,
thus/RB
ensuring/VBG
that/IN
the/DT
remaining/VBG
cytosines/NNS
are/VBP
all/DT
5-mCs/NNS
./.
====================
Histone/NN
modifications/NNS
====================
Chromosomal/JJ
DNA/NN
is/VBZ
wrapped/VBN
around/IN
histone/NN
octamers/NNS
,/,
essentially/RB
composed/VBN
of/IN
4/CD
kinds/NNS
of/IN
subunits/NNS
;/:
viz./FW
,/,
H2A/NN
,/,
H2B/NN
,/,
H3/NN
,/,
and/CC
H4/NN
./.
====================
These/DT
proteins/NNS
are/VBP
subject/JJ
to/TO
chemical/JJ
modifications/NNS
at/IN
specific/JJ
residues/NNS
of/IN
histone/NN
tails/NNS
;/:
some/DT
well-studied/JJ
modifications/NNS
include/VBP
phosphorylation/NN
,/,
methylation/NN
,/,
and/CC
ubiquitination/NN
[/(
38/CD
]/)
./.
====================
These/DT
modifications/NNS
are/VBP
involved/VBN
in/IN
setting/VBG
the/DT
stage/NN
for/IN
directed/JJ
transcriptional/JJ
activation/NN
and/CC
repression/NN
by/IN
controlling/VBG
DNA/NN
accessibility/NN
or/CC
recruitment/NN
of/IN
other/JJ
protein/NN
complexes/NNS
./.
====================
This/DT
idea/NN
has/VBZ
been/VBN
extended/VBN
into/IN
the/DT
``/NN
histone/NN
code/VBP
''/RB
hypothesis/NN
[/(
39/CD
,/,
40/CD
]/)
-that/IN
complex/NN
combinations/NNS
of/IN
distinct/JJ
histone/NN
modifications/NNS
,/,
like/IN
H3K27me3/NN
(/(
a/DT
mark/VBP
of/IN
repressed/VBN
regions/NNS
)/)
,/,
H3K4me3/NNP
(/(
a/DT
mark/VBP
of/IN
gene/NN
promoters/NNS
)/)
,/,
and/CC
H3K27ac/NN
(/(
a/DT
mark/VBP
of/IN
transcriptionally/RB
active/JJ
regions/NNS
)/)
,/,
etc/JJ
./.
====================
[/(
41/CD
]/)
,/,
underlie/VBP
specific/JJ
transcriptional/JJ
programs/NNS
./.
====================
This/DT
notion/NN
has/VBZ
been/VBN
further/RBR
extended/VBD
in/IN
more/RBR
recent/JJ
works/NNS
into/IN
an/DT
'epigenomic/JJ
code/VBP
'/``
to/TO
include/VB
epigenomic/JJ
marks/NNS
other/JJ
than/IN
histone/NN
modifications/NNS
[/(
42/CD
]/)
./.
====================
Chromatin/NN
immunoprecipitation/NN
(/(
ChIP/NN
)/)
of/IN
DNA-histone/NN
complexes/NNS
is/VBZ
achieved/VBN
by/IN
cross-linking/JJ
histones/NNS
with/IN
the/DT
DNA/NN
,/,
digesting/VBG
the/DT
cross-linked/JJ
DNA/NN
,/,
and/CC
then/RB
using/VBG
an/DT
antibody/NN
specific/JJ
to/TO
the/DT
N-tail/NN
modification/NN
of/IN
interest/JJ
(/(
to/TO
any/DT
of/IN
the/DT
>/JJ
100/CD
post-translational/JJ
modifications/NNS
to/TO
histone/NN
tails/NNS
and/CC
globules/NNS
[/(
43/CD
]/)
)/)
,/,
followed/VBN
by/IN
sequencing/VBG
of/IN
the/DT
purified/VBN
DNA/NN
fragments/NNS
./.
====================
This/DT
method/NN
is/VBZ
called/VBN
chromatin/NN
immunoprecipitation/NN
sequencing/NN
(/(
ChIP-seq/NN
)/)
and/CC
was/VBD
primarily/RB
used/VBN
to/TO
map/VB
the/DT
genomic/JJ
locations/NNS
of/IN
DNA-associated/JJ
proteins/NNS
./.
====================
Due/IN
to/TO
the/DT
relatively/RB
large/JJ
fragment/NN
size/NN
,/,
the/DT
mapped/VBN
sequence/NN
reads/VBZ
thus/RB
obtained/VBN
from/IN
ChIP-seq/NN
[/(
21/CD
]/)
provide/VBP
a/DT
low-resolution/JJ
localization/NN
map/VBP
of/IN
modified/VBN
histones/NNS
in/IN
the/DT
genome/NN
./.
====================
An/DT
alternative/JJ
strategy/NN
,/,
chromatin/NN
immunoprecipitation-exonuclease/NN
(/(
ChIP-exo/NNP
)/)
,/,
uses/VBZ
exonuclease/NN
to/TO
digest/VB
the/DT
precipitated/JJ
DNA/NN
fragment/NN
from/IN
either/CC
end/NN
to/TO
better/RBR
resolve/VBP
the/DT
modified/VBN
loci/NNS
at/IN
base-pair/NN
resolution/NN
[/(
22/CD
]/)
./.
====================
Nucleosome/JJ
positioning/JJ
and/CC
occupancy/NN
====================
The/DT
packaging/JJ
of/IN
DNA/NN
coiled/VBD
around/IN
histones/NNS
produces/VBZ
distinct/JJ
structures/NNS
called/VBN
nucleosomes/NNS
that/DT
form/VBP
repeating/VBG
units/NNS
with/IN
approximately/RB
147/CD
bp/NN
wrapped/VBD
around/IN
each/DT
unit/NN
,/,
separated/VBN
by/IN
varying/VBG
lengths/NNS
of/IN
linker/NN
DNA/NN
./.
====================
The/DT
occupancy/NN
and/CC
periodic/JJ
positioning/JJ
of/IN
nucleosomes/NNS
can/MD
control/VB
the/DT
accessibility/NN
of/IN
DNA/NN
to/TO
transcription/NN
factors/NNS
[/(
23/CD
]/)
and/CC
DNases/NNS
,/,
as/IN
well/RB
as/IN
the/DT
transcription/NN
rate/NN
of/IN
active/JJ
gene/NN
bodies/NNS
[/(
44/CD
]/)
,/,
and/CC
are/VBP
thus/RB
considered/VBN
an/DT
epigenetic/JJ
mark/VBP
./.
====================
Biochemically/RB
active/JJ
regulatory/JJ
regions/NNS
are/VBP
generally/RB
depleted/VBN
of/IN
nucleosomes/NNS
[/(
45/CD
]/)
,/,
whereas/IN
inactive/JJ
repeat/NN
regions/NNS
(/(
heterochromatin/NN
)/)
have/VBP
higher/JJR
affinity/NN
to/TO
form/VB
nucleosome/JJ
structures/NNS
[/(
46/CD
]/)
./.
====================
A/DT
map/VBP
of/IN
nucleosome/JJ
occupancy/NN
is/VBZ
generated/VBN
by/IN
using/VBG
micrococcal/JJ
nuclease/NN
(/(
MNase/NN
)/)
for/IN
digestion/NN
of/IN
the/DT
chromatin/NN
[/(
23/CD
]/)
,/,
followed/VBN
by/IN
high-throughput/JJ
sequencing-a/NN
technique/NN
called/VBN
MNase-seq/NN
./.
====================
MNase/NN
digests/NNS
all/DT
linker/NN
DNA/NN
but/CC
preserves/VBZ
the/DT
DNA/NN
wound/NN
around/IN
the/DT
nucleosome/JJ
;/:
when/WRB
the/DT
latter/JJ
is/VBZ
sequenced/VBN
and/CC
mapped/VBD
to/TO
the/DT
reference/NN
,/,
a/DT
map/NN
of/IN
the/DT
original/JJ
positioning/JJ
of/IN
nucleosomes/NNS
is/VBZ
obtained/VBN
./.
====================
Due/IN
to/TO
some/DT
inherent/JJ
biases/NNS
in/IN
MNase/NN
affinity/NN
(/(
preference/NN
to/TO
AT-rich/JJ
regions/NNS
)/)
and/CC
the/DT
lack/NN
of/IN
single/JJ
base-pair/NN
resolution/NN
data/NNS
,/,
attempts/NNS
were/VBD
made/VBN
to/TO
develop/VB
more/RBR
precise/JJ
technologies/NNS
[/(
24/CD
]/)
./.
====================
An/DT
MNase-independent/JJ
technique/NN
that/DT
involves/VBZ
chemically/RB
modifying/VBG
engineered/VBN
histones/NNS
to/TO
bring/VBG
about/RB
cleavage/NN
of/IN
DNA/NN
wound/NN
around/IN
histones/NNS
allows/VBZ
direct/JJ
mapping/NN
of/IN
nucleosome/JJ
centers/NNS
./.
====================
Chromatin/NN
accessibility/NN
====================
Epigenetic/JJ
mechanisms/NNS
,/,
such/JJ
as/IN
chromatin/NN
accessibility/NN
,/,
impact/VBP
transcription/NN
factor/NN
binding/NN
to/TO
DNA/NN
,/,
transcriptional/JJ
specificity/NN
,/,
and/CC
hence/RB
,/,
transcriptional/JJ
regulation/NN
./.
====================
Open/JJ
and/CC
easily/RB
accessible/JJ
regions/NNS
of/IN
DNA/NN
within/IN
the/DT
chromatin/NN
are/VBP
indicative/JJ
of/IN
local/JJ
territories/NNS
of/IN
transcriptional/JJ
activity/NN
./.
====================
Measuring/VBG
``/CD
openness/RB
''/CD
of/IN
DNA/NN
at/IN
different/JJ
regions/NNS
genome-wide/NN
,/,
based/VBN
on/IN
the/DT
DNase/NN
hypersensitivity/NN
assay/NN
,/,
has/VBZ
helped/VBN
discover/RB
several/JJ
classes/NNS
of/IN
functional/JJ
elements/NNS
,/,
like/IN
promoters/NNS
and/CC
enhancers/NNS
[/(
47/CD
]/)
./.
====================
It/PRP
has/VBZ
also/RB
aided/VBD
in/IN
identifying/VBG
cell-type/JJ
specific/JJ
behaviors/NNS
by/IN
comparison/NN
of/IN
accessibility/NN
profiles/NNS
[/(
47/CD
]/)
./.
====================
Regions/NNS
of/IN
accessible/JJ
chromatin/NN
are/VBP
reflective/JJ
of/IN
active/JJ
regulatory/JJ
sites/NNS
./.
====================
The/DT
enzyme/NN
DNase/NN
I/CD
is/VBZ
capable/JJ
of/IN
digesting/VBG
DNA/NN
in/IN
nucleosome-depleted/JJ
regions/NNS
(/(
i.e./FW
,/,
free/JJ
unwound/JJ
DNA/NN
)/)
./.
====================
Post-digestion/NN
sequencing/NN
reveals/VBZ
large/JJ
blocks/VBZ
of/IN
DNase/NN
hypersensitive/JJ
sites/NNS
(/(
DHS/NN
)/)
in/IN
chromatin/NN
(/(
DNase-seq/NN
)/)
[/(
25/CD
,/,
48/CD
]/)
,/,
which/WDT
,/,
upon/IN
further/JJ
deep/VB
sequencing/NN
,/,
can/MD
reveal/VB
up/IN
to/TO
40-bp/JJ
footprints/NNS
of/IN
protected/JJ
regions/NNS
(/(
potentially/RB
bound/VBD
by/IN
transcription/NN
factors/NNS
)/)
./.
====================
These/DT
smaller/JJR
regions/NNS
are/VBP
called/VBN
digital/JJ
genomic/JJ
footprints/NNS
(/(
DGF/NN
)/)
[/(
26/CD
]/)
./.
====================
Formaldehyde-assisted/JJ
isolation/NN
of/IN
regulatory/JJ
elements/NNS
sequencing/VBG
is/VBZ
another/DT
technique/NN
that/DT
,/,
by/IN
deep-sequencing/VBG
random/JJ
fragments/NNS
of/IN
the/DT
genome/NN
post-crosslinking/JJ
,/,
measures/VBZ
the/DT
frequency/NN
of/IN
shearing/VBG
at/IN
different/JJ
loci/NNS
,/,
thus/RB
quantifying/VBG
accessibility/NN
at/IN
high/JJ
resolution/NN
,/,
because/IN
free/JJ
DNA/NN
that/IN
is/VBZ
unbound/JJ
by/IN
factors/NNS
is/VBZ
more/RBR
susceptible/JJ
to/TO
shearing/VBG
[/(
27/CD
]/)
./.
====================
3D/NN
chromatin/NN
architecture/NN
====================
The/DT
array/NN
of/IN
nucleosomes/NNS
organized/VBN
in/IN
30-nm/CD
fibers/NNS
,/,
called/VBN
chromatin/NN
,/,
has/VBZ
diverse/JJ
functions/NNS
well/RB
beyond/IN
mere/VBP
compaction/NN
./.
====================
Coordinated/JJ
activity/NN
of/IN
distal/JJ
elements/NNS
is/VBZ
orchestrated/VBN
by/IN
short-/JJ
and/CC
long-range/JJ
DNA/NN
interactions/NNS
,/,
which/WDT
is/VBZ
determined/VBN
by/IN
the/DT
3D/NN
chromatin/NN
structure/NN
as/IN
well/RB
as/IN
the/DT
local/JJ
environment/NN
of/IN
individual/JJ
genes/NNS
./.
====================
For/IN
instance/NN
,/,
chromatin/NN
conformation/looping/VBG
mediates/VBZ
a/DT
promoter/NN
's/POS
access/VBP
to/TO
its/PRP$
enhancers/NNS
,/,
thereby/RB
determining/VBG
the/DT
transcriptional/JJ
fate/NN
of/IN
a/DT
gene/NN
[/(
49/CD
]/)
./.
====================
Spatial/JJ
proximity/NN
can/MD
be/VB
determined/VBN
by/IN
measuring/VBG
the/DT
interaction/NN
frequencies/NNS
of/IN
linearly/RB
distal/JJ
fragments/NNS
by/IN
a/DT
suite/JJ
of/IN
chromosome/NN
conformation/NN
capture/NN
(/(
3C/NN
)/)
-based/JJ
assays/NNS
./.
====================
Chromosomes/NNS
assume/NN
a/DT
specific/JJ
tertiary/JJ
structure/NN
with/IN
profound/JJ
implications/NNS
for/IN
cellular/JJ
function/NN
and/CC
fate/NN
[/(
49/CD
]/)
./.
====================
While/IN
the/DT
overall/JJ
chromatin/NN
structure/NN
can/MD
not/RB
be/VB
directly/RB
measured/VBN
,/,
measuring/VBG
spatial/JJ
distances/VBZ
between/IN
pairs/NNS
of/IN
genomic/JJ
loci/NNS
has/VBZ
become/VBN
increasingly/RB
more/RBR
efficient/JJ
with/IN
the/DT
arrival/NN
of/IN
3C/NN
technologies/NNS
[/(
28/CD
]/)
./.
====================
Treatment/NN
with/IN
formaldehyde/JJ
crosslinks/VBZ
spatially/RB
proximal/JJ
DNA/NN
loci/NNS
in/IN
cells/NNS
,/,
and/CC
then/RB
post-digestion/NN
,/,
the/DT
resulting/VBG
fragments/NNS
are/VBP
allowed/VBN
to/TO
ligate/JJ
in/IN
a/DT
weak/JJ
solution/NN
(/(
cross-linked/JJ
fragments/NNS
ligate/JJ
with/IN
higher/JJR
frequency/NN
than/IN
random/JJ
fragments/NNS
)/)
./.
====================
This/DT
frequency/NN
is/VBZ
quantitatively/RB
assessed/VBN
by/IN
quantitative/JJ
polymerase/NN
chain/NN
reaction/NN
./.
====================
Known/JJ
loci/NNS
are/VBP
selected/VBN
for/IN
by/IN
using/VBG
sequence-specific/JJ
probes/NNS
that/DT
allow/VBP
assaying/VBG
specific/JJ
pairs/NNS
of/IN
regions/NNS
in/IN
so-called/JJ
one-versus-one/CD
mapping/NN
./.
====================
Circular/JJ
chromosome/NN
conformation/NN
capture/NN
,/,
or/CC
4C/NN
,/,
allows/VBZ
whole-genome/WP$
mapping/VBG
of/IN
all/DT
spatial/JJ
interactions/NNS
of/IN
one/CD
specific/JJ
region/NN
of/IN
interest/NN
(/(
one-vs-all/DT
mapping/VBG
)/)
[/(
29/CD
]/)
./.
====================
Chromosome/NN
conformation/NN
capture/NN
carbon/NN
copy/NN
,/,
or/CC
5C/NN
,/,
deploys/VBZ
several/JJ
anchors/NNS
and/CC
primers/NNS
to/TO
ensure/VB
targeting/VBG
of/IN
several/JJ
regions/NNS
at/IN
once/RB
to/TO
attain/VB
higher/JJR
coverage/NN
(/(
many-vs-many/JJ
)/)
[/(
30/CD
]/)
./.
====================
Finally/RB
,/,
the/DT
most/JJS
recent/JJ
derivative/JJ
of/IN
3C/NN
,/,
namely/RB
Hi-C/NN
,/,
permits/VBZ
surveying/VBG
of/IN
the/DT
whole/JJ
genome/NN
[/(
31/CD
]/)
in/IN
a/DT
relatively/RB
unbiased/JJ
fashion/NN
for/IN
frequencies/NNS
of/IN
spatially/RB
interacting/VBG
pairs/NNS
of/IN
loci/NNS
in/IN
the/DT
entire/JJ
genome/NN
without/IN
restricting/VBG
the/DT
exploration/NN
to/TO
selected/VBN
loci/NNS
./.
====================
This/DT
was/VBD
done/VBN
with/IN
reasonably/RB
high/JJ
resolution/NN
,/,
where/WRB
the/DT
human/JJ
genome/NN
was/VBD
partitioned/VBN
into/IN
100-kb/JJ
blocks/VBZ
and/CC
the/DT
spatial/JJ
interaction/NN
between/IN
every/RB
pair/NN
of/IN
intra-chromosomal/JJ
regions/NNS
was/VBD
assessed/VBN
,/,
while/IN
interchromosomal/JJ
interactions/NNS
have/VBP
been/VBN
mapped/VBN
at/IN
1-Mb/JJ
resolution/NN
[/(
31/CD
]/)
./.
====================
A/DT
variation/NN
of/IN
Hi-C/NN
,/,
called/VBN
chromatin/NN
interaction/NN
analysis/NN
by/IN
paired-end/NN
tag/NN
sequencing/NN
(/(
ChIA-PET/NN
)/)
,/,
involves/VBZ
a/DT
ChIP/NN
reaction/NN
to/TO
isolate/VB
chromatin/NN
interactions/NNS
involving/VBG
regions/NNS
of/IN
DNA/NN
that/IN
bind/VBP
to/TO
a/DT
protein/NN
of/IN
interest/NN
[/(
32/CD
]/)
./.
====================
For/IN
example/NN
,/,
an/DT
antibody/NN
targeting/VBG
RNA/NN
polymerase/NN
II/CD
can/MD
be/VB
used/VBN
to/TO
precipitate/VB
interactions/NNS
involving/VBG
a/DT
promoter/NN
and/CC
another/DT
interacting/VBG
region/NN
,/,
such/JJ
as/IN
a/DT
distal/JJ
enhancer/NN
or/CC
other/JJ
promoters/NNS
[/(
50/CD
]/)
./.
====================
Non-coding/JJ
RNA/NN
localization/NN
====================
Specific/JJ
classes/NNS
of/IN
non-coding/JJ
RNA-short/NN
RNAs/NNS
(/(
viz/NN
./.
====================
micro/RB
RNA/NN
[/(
miRNA/JJ
]/)
,/,
short/JJ
interfering/VBG
RNA/NN
[/(
siRNA/JJ
]/)
,/,
and/CC
piwi-interacting/VBG
RNA/NN
[/(
piRNA/JJ
]/)
)/)
and/CC
long/JJ
non-coding/JJ
RNAs/NNS
(/(
lncRNA/JJ
)/)
-regulate/JJ
gene/NN
expression/NN
through/IN
epigenetic/JJ
mechanisms/NNS
,/,
influencing/VBG
several/JJ
cellular/JJ
processes/NNS
,/,
like/IN
X/NN
chromosome/NN
inactivation/NN
[/(
51/CD
]/)
,/,
genomic/JJ
imprinting/VBG
[/(
52/CD
]/)
,/,
and/CC
some/DT
cellular/JJ
processes/NNS
[/(
53/CD
]/)
,/,
and/CC
cancer/NN
[/(
54/CD
]/)
./.
====================
LncRNAs/NNS
tether/RB
epigenetic/JJ
complexes/NNS
capable/JJ
of/IN
methylating/JJ
DNA/NN
and/CC
modifying/VBG
histones/NNS
to/TO
the/DT
chromatin/NN
,/,
enabling/VBG
allele-/NN
and/CC
locus-specific/JJ
regulation/NN
./.
====================
For/IN
example/NN
,/,
lncRNA/JJ
Xist/NN
covers/NNS
the/DT
inactive/JJ
X/NN
chromosome/NN
and/CC
recruits/VBZ
PCR2/NN
,/,
a/DT
Polycomb/NN
complex/NN
responsible/JJ
for/IN
trimethylation/NN
of/IN
H3K27/NN
[/(
51/CD
]/)
./.
====================
Furthermore/RB
,/,
lncRNAs/NNS
,/,
by/IN
virtue/NN
of/IN
their/PRP$
length/NN
,/,
are/VBP
suited/VBN
for/IN
orchestrating/VBG
specific/JJ
regulatory/JJ
events/NNS
particular/JJ
to/TO
a/DT
target/NN
locus/NN
[/(
55/CD
]/)
./.
====================
Additionally/RB
,/,
miRNA/JJ
(/(
~22/CD
nucleotides/NNS
long/JJ
)/)
have/VBP
shown/VBN
to/TO
be/VB
linked/VBN
with/IN
cancer/NN
and/CC
can/MD
act/VB
as/IN
either/CC
oncogenes/NNS
or/CC
tumor-suppressor/JJ
genes/NNS
./.
====================
They/PRP
can/MD
be/VB
involved/VBN
in/IN
establishing/VBG
DNA/NN
methylation/NN
and/CC
regulating/VBG
histone/NN
modification/NN
by/IN
interacting/VBG
with/IN
their/PRP$
target/NN
mRNA/NN
to/TO
alter/VB
chromatin/NN
of/IN
the/DT
corresponding/JJ
DNA/NN
template/NN
[/(
56/CD
]/)
./.
====================
siRNA/JJ
,/,
and/CC
its/PRP$
interference/NN
machinery/NN
has/VBZ
also/RB
been/VBN
implicated/VBN
in/IN
the/DT
formation/NN
of/IN
heterochromatin/NN
[/(
57/CD
]/)
./.
====================
A/DT
catalog/NN
of/IN
small/JJ
RNAs/NNS
has/VBZ
been/VBN
generated/VBN
by/IN
deep/JJ
sequencing/NN
of/IN
total/JJ
RNA/NN
from/IN
whole/JJ
transcriptomes/VBZ
using/VBG
smRNA-seq/JJ
technology/NN
[/(
34/CD
]/)
./.
====================
Selection/NN
of/IN
smRNA/JJ
can/MD
be/VB
carried/VBN
out/RP
by/IN
sequential/JJ
ligation/NN
of/IN
adapters/NNS
to/TO
its/PRP$
unique/JJ
5/CD
'/``
mono/triphosphate/NN
ends/NNS
,/,
produced/VBN
as/IN
a/DT
result/NN
of/IN
processing/NN
the/DT
smRNA/JJ
population/NN
in/IN
the/DT
cell/NN
[/(
58/CD
]/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
lncRNA/JJ
are/VBP
poly-adenylated/VBN
,/,
and/CC
much/RB
of/IN
the/DT
challenge/NN
in/IN
identifying/VBG
them/PRP
from/IN
whole-genome/DT
mRNA-seq/NN
data/NNS
[/(
33/CD
]/)
lies/VBZ
in/IN
the/DT
computational/JJ
and/CC
analytical/JJ
domains/NNS
[/(
59/CD
]/)
./.
====================
Spurred/JJ
by/IN
unprecedented/JJ
advances/NNS
in/IN
sequencing/VBG
technologies/NNS
as/IN
well/RB
as/IN
other/JJ
assays/NNS
,/,
and/CC
a/DT
recognition/NN
of/IN
the/DT
potential/JJ
of/IN
NGS/NN
in/IN
determining/VBG
the/DT
epigenomic/JJ
landscape/NN
,/,
several/JJ
research/NN
consortia/NN
have/VBP
formed/VBN
to/TO
generate/VB
genome-wide/NN
maps/VBZ
of/IN
human/JJ
epigenomic/JJ
marks/NNS
by/IN
sharing/VBG
resources/VBZ
and/CC
publishing/VBG
standard/JJ
operating/VBG
procedures/NNS
,/,
thereby/RB
ensuring/VBG
best/IN
practices/VBZ
and/CC
high-quality/JJ
datasets/NNS
[/(
60/CD
]/)
./.
====================
One/CD
of/IN
the/DT
first/JJ
concerted/JJ
efforts/NNS
in/IN
this/DT
direction/JJ
was/VBD
the/DT
Encyclopedia/NN
of/IN
DNA/NN
Elements/NNS
(/(
ENCODE/NNP
)/)
Project/JJ
,/,
started/VBD
in/IN
2003/CD
and/CC
funded/VBD
by/IN
the/DT
National/JJ
Human/JJ
Genome/NN
Research/NN
Institute/RB
at/IN
the/DT
National/JJ
Institute/RB
of/IN
Health/NN
(/(
NIH-NHGRI/NN
)/)
,/,
which/WDT
involved/VBD
hundreds/VBZ
of/IN
researchers/NNS
in/IN
dozens/NNS
of/IN
labs/NNS
across/IN
the/DT
globe/NN
./.
====================
The/DT
ENCODE/NN
consortium/NN
has/VBZ
performed/VBN
1,650/CD
epigenomic/JJ
profiling/VBG
on/IN
147/CD
cell/NN
lines/NNS
assessing/VBG
the/DT
transcriptome/JJ
,/,
transcription/NN
factor/NN
binding/VBG
for/IN
dozens/NNS
of/IN
transcription/NN
factors/NNS
,/,
chromatin/NN
topology/NN
,/,
histone/NN
modifications/NNS
,/,
DNA/NN
methylation/NN
,/,
and/CC
more/RBR
(/(
http/NN
:/:
//www.encodeproject.org/JJ
)/)
[/(
13/CD
]/)
./.
====================
Five/CD
years/NNS
after/IN
launching/VBG
ENCODE/NN
,/,
the/DT
NIH/NN
funded/VBD
a/DT
second/JJ
large-scale/JJ
mapping/NN
project/VB
called/VBN
the/DT
Roadmap/NN
Epigenomics/NNS
Program/NN
./.
====================
While/IN
ENCODE/NN
focused/VBN
on/IN
generating/VBG
data/NNS
in/IN
cell/NN
lines/NNS
,/,
the/DT
Roadmap/NN
program/NN
focuses/VBZ
on/IN
mapping/NN
epigenomes/NNS
of/IN
high-priority/JJ
normal/JJ
human/JJ
primary/JJ
tissue/NN
and/CC
human/JJ
embryonic/JJ
stem/NN
cell/NN
(/(
ESC/NN
)/)
-derived/JJ
cell/NN
types/NNS
./.
====================
As/IN
of/IN
May/JJ
2012/CD
,/,
the/DT
Roadmap/NN
includes/VBZ
61/CD
``/CD
complete/JJ
''/NN
epigenomes/NNS
(/(
of/IN
a/DT
variety/NN
of/IN
cell/NN
types/NNS
)/)
(/(
http/NN
:/:
//www.roadmapepigenomics.org/JJ
)/)
[/(
61/CD
]/)
./.
====================
The/DT
data/NNS
repository/JJ
can/MD
be/VB
accessed/VBN
interactively/RB
at/IN
Human/JJ
Epigenome/JJ
Atlas/IN
(/(
http/NN
:/:
//www.genboree.org/epigenomeatlas/multiGridViewerPublic.rhtml/NN
)/)
,/,
via/IN
the/DT
Washington/NN
University/NN
Epigenome/JJ
Browser/NN
(/(
http/NN
:/:
//www.epigenomegateway.wustl.edu/browser/JJR
)/)
,/,
as/IN
well/RB
as/IN
the/DT
UCSC/NN
Genome/NN
Browser/NN
(/(
http/NN
:/:
//www.genome.ucsc.edu/FW
)/)
./.
====================
Further/RB
,/,
the/DT
NIH/NN
Roadmap/NN
is/VBZ
one/CD
of/IN
the/DT
members/NNS
of/IN
an/DT
even/RB
larger/RBR
consortium/NN
called/VBN
the/DT
International/JJ
Human/JJ
Epigenome/JJ
Consortium/NN
(/(
IHEC/NN
;/:
http/RB
:/:
//www.ihec-epigenomes.org/JJ
)/)
,/,
formed/VBD
by/IN
institutions/NNS
in/IN
7/CD
countries/NNS
./.
====================
To/TO
name/RB
a/DT
few/JJ
,/,
BLUEPRINT/NNP
:/:
a/DT
European/JJ
initiative/JJ
to/TO
generate/VB
about/RB
100/CD
reference/VBP
epigenomic/JJ
maps/VBZ
;/:
the/DT
CREST/IHEC/NN
team/JJ
in/IN
Japan/NNP
:/:
to/TO
produce/VB
reference/RB
epigenomes/NNS
specializing/VBG
in/IN
gastrointestinal/JJ
epithelial/JJ
cells/NNS
,/,
vascular/JJ
endothelial/JJ
cells/NNS
,/,
and/CC
cells/NNS
of/IN
reproductive/JJ
organs/NNS
;/:
and/CC
the/DT
Epigenomic/JJ
Platform/NN
Program/NN
:/:
a/DT
Canadian/JJ
program/NN
to/TO
map/VB
epigenomic/JJ
variations/NNS
in/IN
disease/NN
cells/NNS
./.
====================
Together/RB
,/,
these/DT
efforts/NNS
are/VBP
expected/VBN
to/TO
generate/VB
over/IN
1,000/CD
reference/VBP
human/JJ
epigenomes/NNS
./.
====================
Other/JJ
epigenome/JJ
mapping/NN
efforts/NNS
focused/VBN
on/IN
specific/JJ
disease/NN
areas/NNS
have/VBP
also/RB
been/VBN
undertaken/VBN
./.
====================
These/DT
include/VBP
the/DT
Cancer/NN
Genome/NN
Atlas/IN
(/(
TCGA/NN
)/)
,/,
funded/VBD
by/IN
the/DT
NIH/NN
in/IN
2006/CD
[/(
62/CD
]/)
,/,
which/WDT
is/VBZ
a/DT
part/NN
of/IN
the/DT
International/JJ
Cancer/NN
Genome/NN
Consortium/NN
(/(
ICGC/NN
;/:
http/RB
:/:
//www.icgc.org/JJ
)/)
that/WDT
was/VBD
officially/RB
put/JJ
together/RB
in/IN
2008/CD
./.
====================
By/IN
providing/VBG
a/DT
rich/JJ
functional/JJ
annotation/NN
of/IN
the/DT
genome/NN
,/,
the/DT
numerous/JJ
epigenomic/JJ
datasets/NNS
have/VBP
significantly/RB
improved/VBN
our/PRP$
ability/NN
to/TO
probe/VB
the/DT
mechanisms/NNS
of/IN
gene/NN
regulation/NN
as/IN
well/RB
as/IN
shed/VBN
light/NN
on/IN
disease/NN
processes/NNS
mediated/VBN
by/IN
perturbation/NN
of/IN
normal/JJ
regulatory/JJ
processes/NNS
./.
====================
A/DT
collection/NN
of/IN
30/CD
scientific/JJ
reports/NNS
published/VBN
with/IN
the/DT
initial/JJ
release/NN
of/IN
the/DT
ENCODE/NN
data/NNS
provides/VBZ
a/DT
detailed/JJ
report/NN
of/IN
the/DT
initial/JJ
integrative/JJ
analysis/NN
of/IN
the/DT
epigenomics/NNS
data/NNS
[/(
47/CD
,/,
63/CD
,/,
64/CD
,/,
65/CD
,/,
66/CD
]/)
./.
====================
At/IN
a/DT
basic/JJ
level/NN
,/,
the/DT
data/NNS
have/VBP
revealed/VBN
epigenomic/JJ
signatures/NNS
of/IN
a/DT
variety/NN
of/IN
functional/JJ
elements/NNS
,/,
thus/RB
significantly/RB
enriching/VBG
their/PRP$
annotation/NN
./.
====================
For/IN
instance/NN
,/,
many/JJ
non-coding/JJ
RNAs/NNS
have/VBP
been/VBN
successfully/RB
annotated/JJ
as/IN
a/DT
result/NN
of/IN
deciphering/VBG
an/DT
epigenomic/JJ
code/VBP
specific/JJ
to/TO
their/PRP$
promoters/NNS
and/CC
gene/NN
bodies/NNS
[/(
67/CD
,/,
68/CD
]/)
./.
====================
High-throughput/JJ
profiling/VBG
of/IN
the/DT
histone/NN
modification/NN
HeK4me1/RB
has/VBZ
revealed/VBN
that/IN
it/PRP
is/VBZ
a/DT
characteristic/JJ
mark/VBP
of/IN
enhancer/NN
elements/NNS
;/:
this/DT
,/,
and/CC
other/JJ
correlative/JJ
marks/NNS
have/VBP
enabled/VBN
the/DT
discovery/NN
of/IN
tens/NNS
of/IN
thousands/DT
of/IN
cell-specific/JJ
enhancers/NNS
[/(
69/CD
,/,
70/CD
]/)
in/IN
the/DT
human/JJ
genome/NN
,/,
drastically/RB
improving/VBG
our/PRP$
ability/NN
to/TO
probe/VB
the/DT
mechanisms/NNS
of/IN
transcriptional/JJ
regulation/NN
./.
====================
In/IN
fact/NN
,/,
chromatin/NN
signatures/NNS
specific/JJ
to/TO
promoters/NNS
,/,
enhancers/NNS
,/,
and/CC
repressed/VBD
regions/NNS
,/,
etc./FW
,/,
have/VBP
all/DT
been/VBN
modeled/VBN
by/IN
computational/JJ
methods/NNS
like/IN
ChromHMM/NN
[/(
42/CD
]/)
./.
====================
Furthermore/RB
,/,
by/IN
isolating/VBG
footprints/NNS
of/IN
protected/JJ
DNA/NN
present/JJ
inside/NN
blocks/VBZ
of/IN
hypersensitive/JJ
or/CC
nucleosome-depleted/JJ
DNA/NN
,/,
a/DT
comprehensive/JJ
list/NN
of/IN
potential/JJ
cis-regulatory/JJ
binding/NN
sites/sequences/NNS
has/VBZ
been/VBN
identified/VBN
,/,
despite/IN
the/DT
lack/NN
of/IN
specific/JJ
antibodies/NNS
or/CC
the/DT
knowledge/NN
of/IN
cell-specific/JJ
regulators/NNS
[/(
2/CD
]/)
./.
====================
Availability/NN
of/IN
epigenomic/JJ
data/NNS
has/VBZ
revived/VBN
predictive/JJ
modeling/VBG
of/IN
condition-specific/JJ
gene/NN
expression/NN
./.
====================
For/IN
example/NN
,/,
Dong/JJ
et/FW
al/JJ
./.
====================
[/(
71/CD
]/)
generated/VBN
a/DT
2-step/JJ
quantitative/JJ
model/NN
that/DT
includes/VBZ
genome/NN
localization/NN
data/NNS
for/IN
11/CD
histone/NN
modifications/NNS
and/CC
1/CD
histone/NN
variant/JJ
in/IN
7/CD
human/JJ
cell/NN
lines/NNS
and/CC
gene/NN
expression/NN
data/NNS
quantified/VBN
using/VBG
RNA-seq/JJ
and/CC
cap/NN
analysis/NN
gene/NN
expression/NN
(/(
CAGE/NN
)/)
in/IN
the/DT
nuclear/JJ
and/CC
cytosolic/JJ
compartments/NNS
of/IN
the/DT
cell/NN
./.
====================
The/DT
Pearson/NN
's/POS
correlation/NN
coefficient/JJ
between/IN
their/PRP$
predicted/VBN
and/CC
measured/VBD
expression/NN
levels/NNS
in/IN
about/RB
78/CD
experiments/NNS
ranged/VBD
between/IN
0.6/CD
and/CC
0.9/CD
(/(
median/JJ
r/NN
=/JJ
0.83/CD
)/)
./.
====================
Natarajan/NN
et/FW
al/JJ
./.
====================
[/(
72/CD
]/)
trained/VBN
a/DT
classifier/NN
that/DT
associates/VBZ
cell-specific/JJ
TF/NN
sequence/NN
motif/NN
matches/VBZ
in/IN
DHS/NN
regions/NNS
with/IN
different/JJ
expression/NN
patterns/NNS
in/IN
19/CD
diverse/JJ
cell/NN
types/NNS
,/,
thus/RB
predicting/VBG
cell-type/JJ
specific/JJ
expression/NN
directly/RB
from/IN
regulatory/JJ
elements/NNS
in/IN
open/JJ
chromatin/NN
./.
====================
Prior/JJ
to/TO
the/DT
availability/NN
of/IN
NGS/NN
,/,
details/VBZ
of/IN
the/DT
spatial/JJ
structure/NN
of/IN
chromatin/NN
and/CC
its/PRP$
correlates/VBZ
,/,
as/IN
well/RB
as/IN
its/PRP$
functional/JJ
impacts/NNS
were/VBD
largely/RB
uncharted/JJ
./.
====================
Characterization/NN
of/IN
the/DT
spatial/JJ
proximity/NN
of/IN
distal/JJ
genomic/JJ
elements/NNS
with/IN
3C-derivative/JJ
assays/NNS
has/VBZ
revealed/VBN
a/DT
high/JJ
rate/NN
of/IN
widespread/JJ
promiscuous/JJ
interactions/NNS
among/IN
enhancers/NNS
and/CC
promoters/NNS
./.
====================
For/IN
instance/NN
,/,
more/RBR
than/IN
40/CD
%/NN
of/IN
promoters/NNS
interact/VBP
with/IN
multiple/JJ
distal/JJ
sites/NNS
,/,
and/CC
this/DT
is/VBZ
likely/JJ
true/JJ
for/IN
enhancers/NNS
as/IN
well/RB
[/(
73/CD
]/)
./.
====================
The/DT
spatial/JJ
chromatin/NN
interaction/NN
data/NNS
have/VBP
also/RB
helped/VBD
challenge/NN
some/DT
previously/RB
held/NN
beliefs/VBZ
that/DT
were/VBD
nevertheless/RB
unsupported/JJ
./.
====================
For/IN
instance/NN
,/,
historically/RB
,/,
the/DT
DNA-binding/JJ
protein/NN
CTCF/NN
was/VBD
known/VBN
to/TO
function/VB
,/,
among/IN
other/JJ
things/NNS
,/,
as/IN
an/DT
insulator/NN
that/DT
inhibited/VBD
the/DT
spatial/JJ
interaction/NN
between/IN
an/DT
enhancer/NN
and/CC
its/PRP$
target/NN
promoter/NN
when/WRB
flanking/JJ
a/DT
CTCF-bound/JJ
locus/NN
./.
====================
However/RB
,/,
recent/JJ
5C/NN
data/NNS
showed/VBD
that/IN
almost/RB
60/CD
%/NN
of/IN
all/DT
enhancer-promoter/NN
interactions/NNS
happen/NN
,/,
despite/IN
an/DT
intervening/VBG
CTCF-bound/NN
locus/NN
[/(
74/CD
]/)
./.
====================
In/IN
fact/NN
,/,
there/EX
is/VBZ
increasing/VBG
evidence/NN
that/IN
CTCF/NN
,/,
along/IN
with/IN
cohesin/NN
is/VBZ
involved/VBN
in/IN
coordinating/VBG
long-range/RB
interactions/NNS
between/IN
regulatory/JJ
elements/NNS
,/,
and/CC
that/IN
these/DT
events/NNS
are/VBP
reflective/JJ
of/IN
cell-type/JJ
specific/JJ
transcriptional/JJ
programs/NNS
[/(
75/CD
]/)
./.
====================
With/IN
the/DT
availability/NN
of/IN
putative/JJ
genome-wide/NN
enhancers/NNS
along/IN
with/IN
their/PRP$
cell/NN
type-specific/JJ
activity/NN
profile/NN
across/IN
numerous/JJ
cell/NN
types/NNS
,/,
it/PRP
is/VBZ
now/RB
possible/JJ
to/TO
investigate/VB
an/DT
alternate/JJ
layer/NN
of/IN
transcriptional/JJ
regulation/NN
represented/VBD
by/IN
a/DT
network/NN
of/IN
distal/JJ
enhancers/NNS
that/DT
exhibit/VBP
correlated/VBN
activities/NNS
across/IN
cell/NN
types/NNS
[/(
76/CD
,/,
77/CD
]/)
and/CC
jointly/RB
underlie/VBP
correlated/VBD
expression/NN
of/IN
functionally/RB
linked/VBN
genes/NNS
./.
====================
Such/JJ
analysis/NN
brings/VBZ
forth/IN
an/DT
alternative/JJ
view/NN
of/IN
transcriptional/JJ
regulation/NN
,/,
where/WRB
instead/RB
of/IN
a/DT
single/JJ
gene/NN
regulated/VBN
by/IN
one/CD
or/CC
more/RBR
regulatory/JJ
elements/NNS
,/,
one/CD
ought/RB
to/TO
consider/VB
the/DT
collective/JJ
of/IN
enhancers/NNS
and/CC
genes/NNS
,/,
co-localized/VBD
in/IN
nuclear/JJ
space/NN
to/TO
achieve/VB
coexpression/NN
of/IN
functionally/RB
linked/VBN
genes/NNS
[/(
78/CD
,/,
79/CD
]/)
./.
====================
Epigenomic/JJ
profiling/VBG
along/IN
the/DT
developmental/JJ
time/NN
course/NN
from/IN
ESCs/NNS
to/TO
differentiated/VBN
cells/NNS
has/VBZ
shed/VBN
light/NN
on/IN
transcriptional/JJ
regulatory/JJ
mechanisms/NNS
during/IN
early/JJ
development/NN
./.
====================
For/IN
instance/NN
,/,
comparison/NN
of/IN
the/DT
``/NN
histone/NN
code/VBP
''/CD
between/IN
the/DT
two/CD
developmental/JJ
timeframes/NNS
indicates/VBZ
that/IN
regions/NNS
marked/JJ
by/IN
repressive/JJ
histone/NN
marks/NNS
are/VBP
generally/RB
larger/RBR
in/IN
differentiated/VBN
cells/NNS
and/CC
that/IN
these/DT
regions/NNS
span/VBP
developmental/JJ
genes/NNS
./.
====================
It/PRP
was/VBD
also/RB
noted/VBN
that/IN
the/DT
same/JJ
regions/NNS
are/VBP
more/RBR
accessible/JJ
in/IN
ESCs/NNS
[/(
80/CD
,/,
81/CD
]/)
,/,
thus/RB
suggesting/VBG
an/DT
epigenome-mediated/JJ
regulation/NN
of/IN
developmental/JJ
gene/NN
transcription/NN
./.
====================
Precisely/RB
how/WRB
this/DT
is/VBZ
accomplished/VBN
is/VBZ
yet/RB
to/TO
be/VB
clarified/VBN
./.
====================
The/DT
epigenomic/JJ
data/NNS
and/CC
the/DT
discovery/NN
of/IN
significant/JJ
patterns/NNS
of/IN
epigenomic/JJ
marks/NNS
associated/VBN
with/IN
specific/JJ
functional/JJ
regions/NNS
have/VBP
also/RB
helped/VBD
clarify/VB
genotype-phenotype/JJ
association/NN
data/NNS
./.
====================
Numerous/JJ
GWAS/NN
have/VBP
revealed/VBN
several/JJ
polymorphic/JJ
loci/NNS
associated/VBN
with/IN
various/JJ
diseases/NNS
[/(
82/CD
]/)
./.
====================
However/RB
,/,
a/DT
mechanistic/JJ
interpretation/NN
of/IN
these/DT
signals/NNS
has/VBZ
been/VBN
hampered/VBN
by/IN
the/DT
fact/NN
that/IN
most/JJS
of/IN
the/DT
disease-associated/JJ
genetic/JJ
variants/NNS
reside/NN
in/IN
non-coding/JJ
regions/NNS
with/IN
no/DT
obvious/JJ
functional/JJ
interpretation/NN
./.
====================
By/IN
combining/VBG
epigenomic/JJ
maps/VBZ
and/CC
genetic/JJ
variants/NNS
,/,
it/PRP
was/VBD
found/VBN
that/IN
these/DT
disease-associated/JJ
variants/NNS
are/VBP
enriched/VBN
within/IN
cell/NN
type-specific/JJ
accessible/JJ
(/(
DHS/NN
regions/NNS
)/)
and/CC
active/JJ
regulatory/JJ
regions/NNS
[/(
2/CD
]/)
./.
====================
Also/RB
,/,
an/DT
epigenomic/JJ
model/NN
of/IN
cardiac/JJ
enhancers/NNS
was/VBD
shown/VBN
to/TO
provide/VB
a/DT
better/RBR
causal/JJ
interpretation/NN
of/IN
GWAS/NN
signals/NNS
associated/VBN
with/IN
heart-related/JJ
traits/VBZ
[/(
83/CD
]/)
./.
====================
The/DT
slew/JJ
of/IN
epigenetic/JJ
data/NNS
has/VBZ
revolutionized/VBN
our/PRP$
perception/NN
of/IN
the/DT
human/JJ
genome/NN
./.
====================
Although/IN
not/RB
all/DT
``/CD
epigenetically/RB
marked/JJ
''/NN
regions/NNS
of/IN
the/DT
genome/NN
are/VBP
likely/JJ
to/TO
be/VB
functional/JJ
,/,
it/PRP
is/VBZ
very/RB
likely/RB
that/IN
a/DT
large/JJ
portion/NN
is/VBZ
functional-much/RB
more/RBR
than/IN
the/DT
5-10/CD
%/NN
of/IN
the/DT
genome/NN
that/IN
is/VBZ
deemed/VBN
to/TO
evolve/VB
under/IN
purifying/JJ
selection/NN
[/(
84/CD
,/,
85/CD
]/)
./.
====================
Analysis/NN
of/IN
transcriptional/JJ
and/CC
epigenetic/JJ
data/NNS
has/VBZ
revealed/VBN
that/IN
almost/RB
half/NN
of/IN
the/DT
genome/NN
is/VBZ
involved/VBN
in/IN
carrying/VBG
out/RP
specific/JJ
biochemical/JJ
functions/NNS
[/(
13/CD
]/)
./.
====================
Where/IN
these/DT
biochemical/JJ
functions/NNS
fit/NN
in/IN
the/DT
big/NN
picture/NN
,/,
and/CC
how/WRB
they/PRP
are/VBP
regulated/VBN
are/VBP
still/RB
open/JJ
questions/NNS
./.
====================
Another/DT
fundamental/JJ
problem/NN
is/VBZ
that/DT
the/DT
causal/JJ
relationships/NNS
among/IN
various/JJ
epigenomic/JJ
events/NNS
,/,
such/JJ
as/IN
DNA/NN
methylation/NN
,/,
histone/NN
modifications/NNS
,/,
TF/NN
binding/NN
,/,
and/CC
gene/NN
expression/NN
,/,
etc./FW
,/,
are/VBP
currently/RB
not/RB
well/RB
understood/VBN
./.
====================
Although/IN
correlations/NNS
between/IN
these/DT
events/NNS
have/VBP
been/VBN
well/RB
documented/VBN
in/IN
different/JJ
contexts/NNS
,/,
we/PRP
do/VBP
not/RB
know/VB
if/IN
one/CD
is/VBZ
necessary/JJ
and/or/CC
sufficient/JJ
to/TO
observe/VB
another/DT
./.
====================
Before/IN
the/DT
full/JJ
potential/JJ
of/IN
NGS/NN
in/IN
mapping/VBG
the/DT
epigenome/JJ
can/MD
be/VB
attained/VBN
,/,
several/JJ
technical/JJ
challenges/NNS
need/VBD
to/TO
be/VB
overcome/VBN
./.
====================
For/IN
instance/NN
,/,
techniques/NNS
like/IN
ChIP-seq/NN
,/,
used/VBN
for/IN
profiling/VBG
transcription/NN
factor/NN
binding/NN
and/CC
histone/NN
modifications/NNS
require/VBP
a/DT
large/JJ
amount/NN
of/IN
starting/VBG
material/JJ
,/,
ranging/VBG
up/IN
to/TO
5/CD
million/NN
cells/NNS
./.
====================
Collection/NN
of/IN
such/JJ
a/DT
large/JJ
population/NN
of/IN
primary/JJ
differentiated/VBN
cells/NNS
,/,
progenitors/NNS
,/,
and/CC
those/DT
from/IN
specific/JJ
developmental/JJ
stages/NNS
is/VBZ
inherently/RB
hard/VBP
./.
====================
Heterogeneity/NN
of/IN
a/DT
cell/NN
population/NN
is/VBZ
another/DT
issue/NN
that/WDT
needs/VBZ
to/TO
be/VB
resolved/VBN
./.
====================
It/PRP
is/VBZ
challenging/JJ
to/TO
obtain/VB
a/DT
homogeneous/JJ
population/NN
of/IN
cells/NNS
of/IN
a/DT
singular/JJ
type/NN
from/IN
primary/JJ
tissues/NNS
that/IN
often/RB
contain/VBP
a/DT
heterogeneous/JJ
population/NN
of/IN
cell/NN
types/NNS
,/,
and/CC
it/PRP
is/VBZ
this/DT
lack/NN
of/IN
homogeneity/NN
that/DT
can/MD
adversely/RB
impact/VBP
the/DT
interpretability/NN
and/CC
generalizability/NN
of/IN
the/DT
results/NNS
obtained/VBN
from/IN
analyzing/VBG
the/DT
epigenomic/JJ
data/NNS
./.
====================
Yet/RB
,/,
many/JJ
solutions/NNS
to/TO
tackle/JJ
the/DT
problems/NNS
above/JJ
are/VBP
underway/NN
./.
====================
First/RB
,/,
there/EX
is/VBZ
the/DT
emergence/NN
of/IN
techniques-like/JJ
ChIP-nano/NN
(/(
nano-scale/JJ
ChIP/NN
)/)
,/,
which/WDT
is/VBZ
a/DT
highly/RB
sensitive/JJ
small-scale/JJ
ChIP-seq/NNP
protocol/NN
with/IN
a/DT
requirement/JJ
of/IN
</JJR
50,000/CD
cells/NNS
as/IN
starting/VBG
material/JJ
[/(
86/CD
]/)
,/,
and/CC
single-molecule/JJ
real-time/VBP
sequencing/NN
[/(
87/CD
]/)
,/,
which/WDT
aims/VBZ
at/IN
alleviating/VBG
cell-population/JJ
effects/NNS
during/IN
mapping/VBG
specific/JJ
features/NNS
./.
====================
Second/RB
,/,
methods/NNS
that/IN
are/VBP
aimed/VBN
at/IN
the/DT
targeted/VBN
knock-out/JJ
of/IN
epigenetic/JJ
modifiers/NNS
,/,
like/IN
DNA/NN
methyltransferases/NNS
and/CC
histone/NN
modification/NN
enzymes/NNS
,/,
at/IN
predetermined/JJ
DNA/NN
sequences/NNS
(/(
using/VBG
transcription/NN
activator-like/IN
effector/NN
nucleases/NNS
[/(
TALENs/NNS
]/)
)/)
[/(
88/CD
]/)
,/,
can/MD
help/VB
to/TO
better/RBR
characterize/VBP
the/DT
functional/JJ
relationships/NNS
between/IN
gene/NN
expression/NN
and/CC
epigenetics/NNS
,/,
thus/RB
providing/VBG
proof/NN
of/IN
concept/NN
for/IN
expression/NN
modulation/NN
(/(
also/RB
called/VBN
epigenetic/JJ
editing/VBG
methods/NNS
)/)
[/(
89/CD
]/)
./.
====================
Also/RB
,/,
powerful/JJ
statistical/JJ
approaches/NNS
are/VBP
being/VBG
developed/VBN
to/TO
integrate/VB
data/NNS
[/(
42/CD
,/,
90/CD
]/)
to/TO
resolve/VB
some/DT
of/IN
these/DT
fundamental/JJ
issues/NNS
./.
====================
With/IN
more/RBR
epigenomic/JJ
maps/VBZ
being/VBG
profiled/VBN
,/,
and/CC
more/RBR
effective/JJ
computational/JJ
approaches/NNS
being/VBG
developed/VBN
,/,
we/PRP
are/VBP
inching/VBG
towards/IN
a/DT
holistic/JJ
mechanistic/JJ
understanding/NN
of/IN
cellular/JJ
and/CC
organismal/JJ
processes/NNS
./.
====================
A/DT
schematic/JJ
depicting/VBG
the/DT
context/NN
of/IN
several/JJ
epigenetic/JJ
marks/NNS
on/IN
chromatin/NN
;/:
ranging/VBG
from/IN
DNA/NN
methylation/NN
,/,
nucleosome/JJ
positioning/JJ
patterns/NNS
affecting/VBG
the/DT
size/NN
and/CC
distribution/NN
of/IN
DNase/NN
I/CD
hypersensitive/JJ
sites/NNS
,/,
transcriptional/JJ
activity/NN
at/IN
non-coding/JJ
sites/NNS
leading/VBG
to/TO
the/DT
production/NN
of/IN
small/JJ
and/CC
long/JJ
RNA/NN
,/,
chemical/JJ
modifications/NNS
of/IN
histone/NN
moieties/NNS
(/(
e.g./FW
,/,
mono-/JJ
,/,
di-/RB
and/CC
tri-methylation/NN
of/IN
the/DT
4th/JJ
lysine/NN
of/IN
the/DT
H3/NN
subunit/NN
)/)
,/,
and/CC
chromatin/NN
folding/VBG
to/TO
form/VB
localized/VBD
structures/NNS
in/IN
3D/NN
nuclear/JJ
space/NN
(/(
anticlockwise/JJ
)/)
./.
====================
Adapted/JJ
from/IN
Fig/NN
./.
====================
1/CD
in/IN
Telese/JJ
et/FW
al/JJ
./.
====================
[/(
9/CD
]/)
,/,
Copyright2013/NN
,/,
with/IN
permission/NN
from/IN
Elsevier/NN
./.
====================
A/DT
summary/NN
of/IN
epigenetic/JJ
marks/NNS
,/,
their/PRP$
types/NNS
(/(
wherever/RB
applicable/JJ
)/)
,/,
and/CC
the/DT
NGS-based/JJ
assays/NNS
used/VBD
to/TO
map/VB
their/PRP$
location/NN
and/CC
distribution/NN
====================
